Certified by Founder Lodge
HAYA Therapeutics
Switzerland - Lausanne
START UP
1 Disclosed Funding Rounds $65,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
HAYA Therapeutics is a precision medicines company developing RNA-guided programmable therapeutics targeting the regulatory genome for serious health conditions including cardiovascular disea
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 09 ,2025 | Series A | $65,000,000 |
4see ventures
+ND Capital
Longview Ventures
Apollo Health Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
FOVC | $2,000,000 | (Jan 16, 2026)
CYB3R OPERATIONS | $5,400,000 | (Jan 16, 2026)
Project Eleven | $20,000,000 | (Jan 16, 2026)
depthfirst | $40,000,000 | (Jan 16, 2026)
Quadric | $30,000,000 | (Jan 16, 2026)
